Bi-Level
approved 02/26/2024
approved 02/26/2024
Purpose:
To establish a guideline for the indications and application of Bi-Level Non Invasive Ventilation (NIV).
Noninvasive ventilation (NIV): Refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube). In prehospital care, this can be provided by either:
1. Continuous positive airway pressure (CPAP)
2. Bi-level positive airway pressure (Bi-Level) Indications:
Adult and Pediatric patients, > 12 years of age, in moderate to severe respiratory distress. Asthma, Bronchospasm, Croup, or Stridor: Shortness of Breath and who are:
Spontaneously breathing
Conscious
Able to maintain their own airway
Indications:
Severe Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Near Drowning
respiratory distress that is not alleviated with simple breathing treatments
Contraindications:
Agonal respirations or apneic patients
Patient needs to be able to clear secretions and have no nausea or vomiting
Suspected pneumothorax or chest trauma
Pediatric patients < 12 years of age
Systolic Blood Pressure (SBP) < 80 mmHg in pediatric
Assemble equipment
Explain procedure to patient
Assist patient to use and tolerate the mask and circuit
Use straps to maintain CPAP or BiPAP seal if needed
Transport patient in a position that facilitates continuous visual monitoring and minimizes aspiration risk
Document lung sounds before and after application of CPAP or BiPAP frequently or if clinical change.
Starting CPAP pressure shall be 5 cm H2O. If using BiPAP set IPAP to 9 cm H2O and EPAP to 5 cm H2O.
NIV support pressures may be increased for clinical effect 2.5-5 cm every 5 minutes. Use the lowest NIV pressures which result in clinical improvement to maintain O2 saturation > 90% and improve patient work of breathing.
If a patient becomes unresponsive or has agonal respirations, remove CPAP or BiPAP and assist ventilations with BVM and airway adjuncts.
Monitor patient and response to NIV.
Notify the hospital that a NIV is in use so that equipment can be made available upon arrival at the hospital to continue.
Medication Administration:
A. FiO2 shall be titrated to the least amount needed to maintain SAO2 ≥ 94%.
B. If indicated for wheezing, Albuterol 5 mg will be administered via in line nebulizer utilizing at least 8 liters per minute.
C. One time dose of Atrovent 0.5mg with Albuterol 5mg (duo-neb) is appropriate.